AI model to improve clinical trial recruitment for eye disease

A new artificial intelligence (AI) system that could significantly reduce the time and cost required to recruit clinical trial patients for an advanced form of age-related vision loss has been developed by a team led by UCL and Moorfields Eye Hospital researchers. The system focuses on Geographic Atrophy (GA), an advanced form of dry age-related macular degeneration (AMD) leading to irreversible vision loss and legal blindness. Until recently there were no effective treatments for GA, which affects 5 to 10 million people globally, but FDA approval in 2023 of two Read More

Related posts:

  1. Cholesterol-lowering drug slows progression of eye disease in people with diabetes: Clinical trial
  2. Deep machine-learning speeds assessment of fruit fly heart aging and disease, a model for human disease
  3. Clinical trial investigates using electronic alerts to help control blood pressure
  4. Breakthrough brain recording device receives FDA approval for a clinical trial
  5. First-of-its-kind clinical trial eliminates or shrinks melanoma tumors in 70% of patients
  6. Clinical trial shows promising results in a two-drug combination that curbs methamphetamine use
  7. Researchers say AI accurately screens heart failure patients for clinical trial eligibility
  8. Clinical trial could lead to new ‘gold standard’ test for prostate cancer detection

Leave a Reply

Your email address will not be published. Required fields are marked *